Evidence map›Paper›PMID 24891505›Full record

ArticleThe Journal of biological chemistry2014

Two amino acid residues confer different binding affinities of Abelson family kinase SRC homology 2 domains for phosphorylated cortactin.

Stacey M Gifford, Weizhi Liu, Christopher C Mader, Tiffany L Halo, Kazuya Machida, Titus J Boggon, Anthony J Koleske

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Cortactin in Lung Cell Function and Disease.International journal of molecular sciences · 2022
    Review
  2. Review
  3. Abl2:Cortactin Interactions Regulate Dendritic Spine Stability via Control of a Stable Filamentous Actin Pool.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Stacey M GiffordFrom the Departments of Molecular Biophysics and Biochemistry.
Weizhi LiuPharmacology.
Christopher C MaderCell Biology, and.
Tiffany L HaloChemistry.
Kazuya Machidathe Department of Genetics and Developmental Biology, Raymond and Beverly Sackler Laboratory of Genetics and Molecular Medicine, University of Connecticut Health Center, Farmington, Conneticut 06030.
Titus J BoggonPharmacology, the Yale Cancer Center, titus.boggon@yale.edu.
Anthony J KoleskeFrom the Departments of Molecular Biophysics and Biochemistry, the Yale Cancer Center, Interdepartmental Neuroscience Program, and Department of Neurobiology, Yale University, New Haven, Connecticut 06520 and anthony.koleske@yale.edu.
Yale University · USYale Cancer Center · USUConn Health · US

Funding

Roles of Abl and Arg Neuronal DevelopmentR01NS039475 · NINDS · YALE UNIVERSITY · PI KOLESKE, ANTHONY J · 2000 to 2012
$4.3M
Functional Role of NCK and CRK Binding InteractionsR01CA082258 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MAYER, BRUCE J. · 1999 to 2012
$4.2M
Supplement to Regulation of invadopodia formation in breast cancer cellsR01CA133346 · NCI · YALE UNIVERSITY · PI KOLESKE, ANTHONY J · 2009 to 2016
$2.3M
Structural basis of Jak3-mediated interleukin-2 family signal transductionR01AI075133 · NIAID · YALE UNIVERSITY · PI BOGGON, TITUS JONATHON · 2007 to 2011
$2.2M
The mechanism of Arg kinase activation by integrin B1R01GM100411 · NIGMS · YALE UNIVERSITY · PI BOGGON, TITUS JONATHON, KOLESKE, ANTHONY J · 2012 to 2015
$1.3M
NCI NIH HHS CA133346NCI NIH HHS R01 CA133346NCI NIH HHS R01 CA82258NIAID NIH HHS AI075133NIAID NIH HHS R01 AI075133NIGMS NIH HHS GM100411NIGMS NIH HHS R01 GM100411NINDS NIH HHS NS39475NINDS NIH HHS R01 NS039475
6 · The paper itself

Abstract

The closely related Abl family kinases, Arg and Abl, play important non-redundant roles in the regulation of cell morphogenesis and motility. Despite similar N-terminal sequences, Arg and Abl interact with different substrates and binding partners with varying affinities. This selectivity may be due to slight differences in amino acid sequence leading to differential interactions with target proteins. We report that the Arg Src homology (SH) 2 domain binds two specific phosphotyrosines on cortactin, a known Abl/Arg substrate, with over 10-fold higher affinity than the Abl SH2 domain. We show that this significant affinity difference is due to the substitution of arginine 161 and serine 187 in Abl to leucine 207 and threonine 233 in Arg, respectively. We constructed Abl SH2 domains with R161L and S187T mutations alone and in combination and find that these substitutions are sufficient to convert the low affinity Abl SH2 domain to a higher affinity "Arg-like" SH2 domain in binding to a phospho-cortactin peptide. We crystallized the Arg SH2 domain for structural comparison to existing crystal structures of the Abl SH2 domain. We show that these two residues are important determinants of Arg and Abl SH2 domain binding specificity. Finally, we expressed Arg containing an "Abl-like" low affinity mutant Arg SH2 domain (L207R/T233S) and find that this mutant, although properly localized to the cell periphery, does not support wild type levels of cell edge protrusion. Together, these observations indicate that these two amino acid positions confer different binding affinities and cellular functions on the distinct Abl family kinases.

Indexed as

Amino Acid SubstitutionAnimalsCells, CulturedCortactinCrystallography, X-RayFibroblastsHumansMiceMice, KnockoutMutation, MissenseProtein BindingProto-Oncogene Proteins c-ablsrc Homology DomainsStructure-Activity RelationshipCortactinCTTN protein, humanProto-Oncogene Proteins c-ablActinCrystal StructurePhosphotyrosineSrc Homology 2 Domain (SH2 Domain)Tyrosine-Protein Kinase (Tyrosine Kinase)

Identifiers

PMID24891505
PMCPMC4094080
OpenAlexW1967298592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.